C J Melief

3.0k total citations · 1 hit paper
41 papers, 2.5k citations indexed

About

C J Melief is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, C J Melief has authored 41 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 12 papers in Oncology and 8 papers in Genetics. Recurrent topics in C J Melief's work include Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (10 papers) and T-cell and B-cell Immunology (10 papers). C J Melief is often cited by papers focused on Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (10 papers) and T-cell and B-cell Immunology (10 papers). C J Melief collaborates with scholars based in Netherlands, United States and Sweden. C J Melief's co-authors include W. Martin Kast, Maarten Zijlstra, Arie C. Voordouw, John Sidney, H M Grey, Ralph T. Kubo, Marika Guercio, Antonella Vitiello, A.J. van der Eb and J Ruppert and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

C J Melief

40 papers receiving 2.4k citations

Hit Papers

The relationship between class I binding affinity and imm... 1994 2026 2004 2015 1994 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C J Melief Netherlands 21 1.8k 864 559 392 382 41 2.5k
C J Melief Netherlands 23 1.4k 0.8× 512 0.6× 430 0.8× 339 0.9× 120 0.3× 36 1.8k
Mary Trounstine United States 16 1.4k 0.8× 668 0.8× 452 0.8× 366 0.9× 213 0.6× 18 2.4k
Joyce M. Zarling United States 22 1.2k 0.7× 424 0.5× 379 0.7× 389 1.0× 228 0.6× 26 2.0k
Toshitada Takemori Japan 37 3.1k 1.8× 871 1.0× 423 0.8× 321 0.8× 188 0.5× 86 4.2k
Marie‐Alix Peyrat France 34 2.8k 1.6× 428 0.5× 844 1.5× 532 1.4× 147 0.4× 68 3.5k
Joel M. Depper United States 11 1.8k 1.0× 419 0.5× 386 0.7× 314 0.8× 110 0.3× 14 2.6k
David Stephany United States 21 1.7k 0.9× 404 0.5× 401 0.7× 287 0.7× 141 0.4× 35 2.6k
Maria Ferrantini Italy 27 1.7k 0.9× 768 0.9× 902 1.6× 248 0.6× 295 0.8× 47 2.5k
Suzanne B. Hartley United States 14 2.9k 1.6× 633 0.7× 349 0.6× 220 0.6× 307 0.8× 14 3.5k
Dirk R. Gewert United Kingdom 26 1.6k 0.9× 878 1.0× 802 1.4× 320 0.8× 204 0.5× 44 2.6k

Countries citing papers authored by C J Melief

Since Specialization
Citations

This map shows the geographic impact of C J Melief's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C J Melief with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C J Melief more than expected).

Fields of papers citing papers by C J Melief

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C J Melief. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C J Melief. The network helps show where C J Melief may publish in the future.

Co-authorship network of co-authors of C J Melief

This figure shows the co-authorship network connecting the top 25 collaborators of C J Melief. A scholar is included among the top collaborators of C J Melief based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C J Melief. C J Melief is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Melief, C J. (1996). Peptide-based cancer vaccines. Current Opinion in Immunology. 8(5). 651–657. 73 indexed citations
2.
Kono, Koji, Maaike E. Ressing, Remco M.P. Brandt, et al.. (1996). Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer.. PubMed. 2(11). 1825–8. 141 indexed citations
3.
Sette, Alessandro, Antonella Vitiello, P Fowler, et al.. (1994). The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.. The Journal of Immunology. 153(12). 5586–5592. 724 indexed citations breakdown →
4.
Kast, W. Martin, L. Roux, Arie C. Voordouw, et al.. (1991). Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.. Proceedings of the National Academy of Sciences. 88(6). 2283–2287. 290 indexed citations
5.
Melief, C J, Rienk Offringa, Alice J.A.M. Sijts, et al.. (1989). Immunosurveillance of Virus-induced Tumors. Cold Spring Harbor Symposia on Quantitative Biology. 54(0). 597–603. 7 indexed citations
6.
Matthews, Eric, et al.. (1989). Distinct chromosomal abnormalities in murine leukemia virus‐induced T‐ and B‐cell lymphomas. International Journal of Cancer. 43(6). 1112–1119. 5 indexed citations
7.
Stam, Nico J., et al.. (1989). Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells.. The Journal of Immunology. 142(11). 4113–4117. 35 indexed citations
8.
Vyth‐Dreese, Florry A., et al.. (1988). Idiotypic immunoglobulin secretion by human B cell non-Hodgkin's lymphomas is related to the expression of the interleukin-2 receptor.. PubMed. 2(4). 231–5. 1 indexed citations
9.
Boog, Claire J. P., Jolande Boes, & C J Melief. (1988). Role of dendritic cells in the regulation of class I restricted cytotoxic T lymphocyte responses.. The Journal of Immunology. 140(10). 3331–3337. 31 indexed citations
10.
Radaszkiewicz, T, et al.. (1987). Refinement and precision in the classification of murine lymphomas by genotyping with immunoglobulin and T cell receptor probes.. PubMed. 1(3). 155–62. 17 indexed citations
12.
Zijlstra, Maarten, et al.. (1986). Imbalanced MHC class II molecule expression at surface of murine B cell lymphomas.. The Journal of Experimental Medicine. 163(5). 1213–1226. 7 indexed citations
13.
Zijlstra, Maarten, et al.. (1986). THE H‐2 COMPLEX REGULATES BOTH THE SUSCEPTIBILITY TO MOUSE VIRAL LYMPHOMAGENESIS AND THE PHENOTYPE OF THE VIRUS‐INDUCED LYMPHOMAS. International Journal of Immunogenetics. 13(2-3). 69–76. 3 indexed citations
14.
Poels, Lambert G., et al.. (1984). Further evidence against random polyclonal antibody formation in mice with lupus-like graft-vs-host disease.. The Journal of Immunology. 132(4). 1814–1820. 39 indexed citations
15.
Selten, Gerard C.M., H. T. M. Cuypers, Maarten Zijlstra, C J Melief, & A Berns. (1984). Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation.. The EMBO Journal. 3(13). 3215–3222. 208 indexed citations
16.
Waal, Leo P. de, W. Martin Kast, Roger W. Melvold, & C J Melief. (1983). Regulation of the cytotoxic T lymphocyte response against Sendai virus analyzed with H-2 mutants.. The Journal of Immunology. 130(3). 1090–1096. 51 indexed citations
17.
Vlug, A, et al.. (1981). Genes of the H-2 complex regulate the antibody response to murine leukemia virus.. The Journal of Immunology. 126(6). 2355–2360. 29 indexed citations
18.
Melief, C J, Somnath Datta, Stephen Louie, et al.. (1975). Splenocyte Plaque Assay for the Detection of Murine Leukemia Virus. Experimental Biology and Medicine. 149(4). 1015–1018. 25 indexed citations
19.
Melief, C J, et al.. (1973). Failure to demonstrate immunity to leukemia associated antigens by lymphocyte transformation in vitro. International Journal of Cancer. 11(1). 11–18. 8 indexed citations
20.
Melief, C J, Mia van der Hart, C. P. Engelfriet, & J. J. van Loghem. (1967). Immune Adherence of Leucocytes and Fibroblasts Derived from Skin, Sensitized by Cytotoxic Leucocyte Iso‐Antibodies and Complement, to the Surface of Indicator Cells. Vox Sanguinis. 12(5). 374–389. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026